Internal Server Error

ChemoMetec - About the company

ChemoMetec is a public company based in Alleroed (Denmark), founded in 1997. It operates as an Automated cell counters and analyzers. ChemoMetec has raised an undisclosed amount in funding. The company has 38 active competitors, including 9 funded and 4 that have exited. Its top competitors include companies like LUMICKS, Xcell Biosciences and Biolog.

Company Details

ChemoMetec develops automated cell counters and analyzers, as well as associated consumables. Its flagship product range NucleoCounter has four different cytometers that use automated image analysis and fluorescent markers for cell counting, a sperm counter, a yeast cell counter, and two different somatic cell counters. Assays that can be performed on the cytometers include cell death and apoptosis assays, cell cycle assays, DNA fragmentation assays, transfection efficiency assays, mitochondrial potential assays, cell viability assays, vitality assays, mammalian and aggregated cell assays, whole blood assays, and the company's proprietary FlexiCyte assay for mammalian cell analysis.
Social
XFacebook
Email ID
*****@chemometec.com
Phone Number
+45 **********
Registered Address
Sacramento, California
Key Metrics
Founded Year
1997
Location
Alleroed, Denmark
Stage
Public
Investors
Ranked
Employee Count
191 as on Aug 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public

ChemoMetec's IPO details

ChemoMetec got listed on Dec 22, 2006.
Click here to take a look at ChemoMetec's IPO in detail
Sign up to download ChemoMetec's company profile

ChemoMetec's funding and investors

ChemoMetec has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Oct 01, 2020 for $*****. 1 investor participated in its latest round. ChemoMetec has 1 institutional investor.

Here is the list of recent funding rounds of ChemoMetec:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Oct 01, 2020
4615233
Grant (prize money)
2659924
8641608
2745852
5430385
lockAccess funding benchmarks and valuations. Sign up today!

ChemoMetec's founders and board of directors

Founder? Claim Profile

ChemoMetec's employee count trend

ChemoMetec has 191 employees as of Aug 26. Here is ChemoMetec's employee count trend over the years:
Employee count trend for ChemoMetec
lockUncover ChemoMetec's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

ChemoMetec's Competitors and alternates

Top competitors of ChemoMetec include LUMICKS, Xcell Biosciences and Biolog. Here is the list of Top 10 competitors of ChemoMetec, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for LUMICKS
LUMICKS
2014, Amsterdam (Netherlands), Series D
Manufacturer of optical tweezers for single molecule analysis instruments
$93.4M
63/100
2nd
Logo for Xcell Biosciences
Xcell Biosciences
2012, San Francisco (United States), Series B
Developer of cell culture analysis device for cancer research
$40.9M
59/100
3rd
Logo for Biolog
Biolog
1984, Hayward (United States), Series A
Provider of cell-based phenotyping technologies and assays
$33.6M
58/100
4th
Logo for IsoPlexis
IsoPlexis
2012, New Haven (United States), Acquired
Developer of multiplexed single-cell analysis tools for the diagnostics and life science research
$186M
54/100
5th
Logo for Axion Biosystems
Axion Biosystems
2007, Atlanta (United States), Acquired
Develops multi-electrode array technology to provide access to cellular information analysis
$20.3M
53/100
6th
Logo for LevitasBio
LevitasBio
2017, San Francisco (United States), Series C
Developer of single-cell imaging and profiling platform based on magnetic levitation technology
$73.8M
49/100
7th
Logo for Lucid Scientific
Lucid Scientific
2012, Atlanta (United States), Series A
Developer of real-time cell analysers
$13.4M
44/100
8th
Logo for ChemoMetec
ChemoMetec
1997, Alleroed (Denmark), Public
Automated cell counters and analyzers
-
43/100
9th
Logo for Curiosis
Curiosis
2015, South Korea, Public
Developer of automation technologies for life science research laboratories
-
42/100
10th
Logo for CEIDOS
CEIDOS
2019, Monthey (Switzerland), Funding Raised
Provider of cell culturing devices for patients cells modification
-
32/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on ChemoMetec's competitors? Click here to see the top ones

ChemoMetec's Investments and acquisitions

ChemoMetec has a total of 1 investment in Arctic Therapeutics. ChemoMetec has not made any acquisitions as of now.

Reports related to ChemoMetec

Here is the latest report on ChemoMetec's sector:

News related to ChemoMetec

lockFilter this list
Media has covered ChemoMetec for a total of 14 events in the last 1 year, 3 of them have been about company updates and 2 about people movement.
•
ChemoMetec A/S Initiates Share Buy-Back ProgramGlobeNewswire•Oct 09, 2026•ChemoMetec
•
ChemoMetec A/S Completes Share Buyback ProgrammeGlobeNewswire•Oct 02, 2026•ChemoMetec
•
Appointment of new CFOGlobeNewswire•Aug 01, 2026•ChemoMetec
•
ChemoMetec A/S Initiates Share Buyback ProgramGlobeNewswire•May 15, 2026•ChemoMetec, Danske Bank
•
ChemoMetec A/S: Growth in revenue and operating profitGlobeNewswire•May 06, 2026•ChemoMetec
•
Notification of managers’ transactionsGlobeNewswire•Feb 09, 2026•ChemoMetec
•
ChemoMetec Enters Letter of Intent With Roche DiagnosticsGlobeNewswire•Feb 04, 2026•ChemoMetec, Roche
•
Interim report 2025/26 - Organic growth despite challengesGlobeNewswire•Feb 04, 2026•ChemoMetec
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about ChemoMetec

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford